Instil Bio, Inc. (TIL)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Bronson Crouch | Chairman & CEO | 1.65M | -- | 1973 |
| Dr. Sandeep Laumas M.D. | CFO & Chief Business Officer | 1.02M | -- | 1969 |
| Dr. James Freedman M.D., Ph.D. | Chief Medical Officer | -- | -- | -- |
| Dr. Qiying Lu M.D. | Chief Medical Officer & Senior VP of China | -- | -- | 1975 |
| Dr. Rupal Bhatt M.D., Ph.D. | Senior VP of Science & Translational Medicine | -- | -- | -- |
Instil Bio, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 14
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Corporate Governance
Upcoming Events
August 11, 2025 at 10:59 AM UTC - August 15, 2025 at 12:00 PM UTC
Instil Bio, Inc. Earnings Date
Recent Events
November 19, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission